222 related articles for article (PubMed ID: 15372073)
1. Tissue plasminogen activator is a potent activator of PDGF-CC.
Fredriksson L; Li H; Fieber C; Li X; Eriksson U
EMBO J; 2004 Oct; 23(19):3793-802. PubMed ID: 15372073
[TBL] [Abstract][Full Text] [Related]
2. Structural requirements for activation of latent platelet-derived growth factor CC by tissue plasminogen activator.
Fredriksson L; Ehnman M; Fieber C; Eriksson U
J Biol Chem; 2005 Jul; 280(29):26856-62. PubMed ID: 15911618
[TBL] [Abstract][Full Text] [Related]
3. Tissue-type plasminogen activator is not necessary for platelet-derived growth factor-c activation.
Riehle KJ; Johnson MM; Johansson F; Bauer RL; Hayes BJ; Gilbertson DG; Haran AC; Fausto N; Campbell JS
Biochim Biophys Acta; 2014 Feb; 1842(2):318-25. PubMed ID: 24269585
[TBL] [Abstract][Full Text] [Related]
4. Activation of the epidermal growth factor signalling pathway by tissue plasminogen activator in pancreas cancer cells.
Hurtado M; Lozano JJ; Castellanos E; López-Fernández LA; Harshman K; Martínez-A C; Ortiz AR; Thomson TM; Paciucci R
Gut; 2007 Sep; 56(9):1266-74. PubMed ID: 17452424
[TBL] [Abstract][Full Text] [Related]
5. Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke.
Su EJ; Cao C; Fredriksson L; Nilsson I; Stefanitsch C; Stevenson TK; Zhao J; Ragsdale M; Sun YY; Yepes M; Kuan CY; Eriksson U; Strickland DK; Lawrence DA; Zhang L
Acta Neuropathol; 2017 Oct; 134(4):585-604. PubMed ID: 28725968
[TBL] [Abstract][Full Text] [Related]
6. The uPA/uPAR system regulates the bioavailability of PDGF-DD: implications for tumour growth.
Ehnman M; Li H; Fredriksson L; Pietras K; Eriksson U
Oncogene; 2009 Jan; 28(4):534-44. PubMed ID: 18997817
[TBL] [Abstract][Full Text] [Related]
7. Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke.
Su EJ; Fredriksson L; Geyer M; Folestad E; Cale J; Andrae J; Gao Y; Pietras K; Mann K; Yepes M; Strickland DK; Betsholtz C; Eriksson U; Lawrence DA
Nat Med; 2008 Jul; 14(7):731-7. PubMed ID: 18568034
[TBL] [Abstract][Full Text] [Related]
8. Plasmin is the major protease responsible for processing PDGF-C in the vitreous of patients with proliferative vitreoretinopathy.
Lei H; Velez G; Hovland P; Hirose T; Kazlauskas A
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):42-8. PubMed ID: 18172073
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells.
Ustach CV; Kim HR
Mol Cell Biol; 2005 Jul; 25(14):6279-88. PubMed ID: 15988036
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor 2 and transforming growth factor beta1 synergism in human bronchial smooth muscle cell proliferation.
Bossé Y; Thompson C; Stankova J; Rola-Pleszczynski M
Am J Respir Cell Mol Biol; 2006 Jun; 34(6):746-53. PubMed ID: 16439802
[TBL] [Abstract][Full Text] [Related]
11. Alveolar macrophages stimulated with titanium dioxide, chrysotile asbestos, and residual oil fly ash upregulate the PDGF receptor-alpha on lung fibroblasts through an IL-1beta-dependent mechanism.
Lindroos PM; Coin PG; Badgett A; Morgan DL; Bonner JC
Am J Respir Cell Mol Biol; 1997 Mar; 16(3):283-92. PubMed ID: 9070613
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-alphaalpha and -alphabeta receptors.
Cao R; Bråkenhielm E; Li X; Pietras K; Widenfalk J; Ostman A; Eriksson U; Cao Y
FASEB J; 2002 Oct; 16(12):1575-83. PubMed ID: 12374780
[TBL] [Abstract][Full Text] [Related]
13. Platelet-derived growth factor-C (PDGF-C) activation by serine proteases: implications for breast cancer progression.
Hurst NJ; Najy AJ; Ustach CV; Movilla L; Kim HR
Biochem J; 2012 Feb; 441(3):909-18. PubMed ID: 22035541
[TBL] [Abstract][Full Text] [Related]
14. Regulation of fibrogenic/fibrolytic genes by platelet-derived growth factor C, a novel growth factor, in human dermal fibroblasts.
Jinnin M; Ihn H; Mimura Y; Asano Y; Yamane K; Tamaki K
J Cell Physiol; 2005 Feb; 202(2):510-7. PubMed ID: 15389578
[TBL] [Abstract][Full Text] [Related]
15. Increased bone formation in mice lacking plasminogen activators.
Daci E; Everts V; Torrekens S; Van Herck E; Tigchelaar-Gutterr W; Bouillon R; Carmeliet G
J Bone Miner Res; 2003 Jul; 18(7):1167-76. PubMed ID: 12854826
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor II receptor, transforming growth factor-beta, and Cdk4 expression and the developmental epigenetics of mouse palate morphogenesis and dysmorphogenesis.
Melnick M; Chen H; Buckley S; Warburton D; Jaskoll T
Dev Dyn; 1998 Jan; 211(1):11-25. PubMed ID: 9438420
[TBL] [Abstract][Full Text] [Related]
17. Tissue plasminogen activator induces microglial inflammation via a noncatalytic molecular mechanism involving activation of mitogen-activated protein kinases and Akt signaling pathways and AnnexinA2 and Galectin-1 receptors.
Pineda D; Ampurdanés C; Medina MG; Serratosa J; Tusell JM; Saura J; Planas AM; Navarro P
Glia; 2012 Apr; 60(4):526-40. PubMed ID: 22162045
[TBL] [Abstract][Full Text] [Related]
18. PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor.
Li X; Pontén A; Aase K; Karlsson L; Abramsson A; Uutela M; Bäckström G; Hellström M; Boström H; Li H; Soriano P; Betsholtz C; Heldin CH; Alitalo K; Ostman A; Eriksson U
Nat Cell Biol; 2000 May; 2(5):302-9. PubMed ID: 10806482
[TBL] [Abstract][Full Text] [Related]
19. The role of platelet-derived growth factor signaling in healing myocardial infarcts.
Zymek P; Bujak M; Chatila K; Cieslak A; Thakker G; Entman ML; Frangogiannis NG
J Am Coll Cardiol; 2006 Dec; 48(11):2315-23. PubMed ID: 17161265
[TBL] [Abstract][Full Text] [Related]
20. Platelet-derived growth factor-AA and -alpha receptor expression suggests an autocrine and/or paracrine loop in osteosarcoma.
Sulzbacher I; Träxler M; Mosberger I; Lang S; Chott A
Mod Pathol; 2000 Jun; 13(6):632-7. PubMed ID: 10874667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
